FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Lopes-Virella

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Phenomena

Oxidation-Reduction

Co-author Network

Publications

TOP 3
Gabriel Virella; Nathaniel L Baker; Charlyne Chassereau; Joan Colglazier; Kelly J Hunt; Maria F Lopes-Virella
Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.
Maria F Lopes-Virella; Thomas Moritz; Gabriel Virella; Nathaniel L Baker; Kelly J Hunt
The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
Tanya N Turan; Nicole Vilardo; Carole L White; Oscar Benavente; W Virgil Brown; Michelle F Caskey; Marc I Chimowitz; Colin P Derdeyn; Brent M Egan; David Fiorella; Kathie L Hermayer; Scott Janis; Bethany Lane; Ngoc-Anh Le; Maria F Lopes-Virella; Michael J Lynn; Azhar Nizam; Meghan R Steiner; Andrew Stufflebean
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Lopes-Virella (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gabriel Virella; Nathaniel L Baker; Charlyne Chassereau; Joan Colglazier; Kelly J Hunt; Maria F Lopes-Virella
Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.
Journal of immunoassay & immunochemistry 2013;34(1):61-74.
2012: Maria F Lopes-Virella; Thomas Moritz; Gabriel Virella; Nathaniel L Baker; Kelly J Hunt
The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
Atherosclerosis 2012;224(2):526-31.
2012: Tanya N Turan; Nicole Vilardo; Carole L White; Oscar Benavente; W Virgil Brown; Michelle F Caskey; Marc I Chimowitz; Colin P Derdeyn; Brent M Egan; David Fiorella; Kathie L Hermayer; Scott Janis; Bethany Lane; Ngoc-Anh Le; Maria F Lopes-Virella; Michael J Lynn; Azhar Nizam; Meghan R Steiner; Andrew Stufflebean
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
Circulation. Cardiovascular quality and outcomes 2012;5(5):e51-60.
2012: Zhongyang Lu; Xiaoming Zhang; Junfei Jin; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(7):1696-706.
2012: Maria F Lopes-Virella; Timothy J Lyons; Gabriel Virella; Nathaniel L Baker; Kelly J Hunt; Alicia J Jenkins
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
Diabetes care 2012;35(6):1333-40.
2012: Junfei Jin; Yanchun Li; Maria F Lopes-Virella; Zhongyang Lu; Devadoss J Samuvel; Kamala Sundararaj; Xiaoming Zhang; Yan Huang
Different signaling mechanisms regulating IL-6 expression by LPS between gingival fibroblasts and mononuclear cells: seeking the common target.
Clinical immunology (Orlando, Fla.) 2012;143(2):188-99.
2012: Jean-Philip Truman; Gabriel Virella; Mohammed M Al Gadban; Alicja Bielawska; Yusuf A Hannun; Russell W Jenkins; Maria F Lopes-Virella; Nalini Mayroo; Kent J Smith; Samar M Hammad
Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release.
Immunology 2012;136(1):30-45.
2012: Maria F Lopes-Virella; Gabriel Virella; Nathaniel L Baker; Rickey E Carter; John Lachin
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(4):1416-23.
2012: Gabriel Virella; Maria F Lopes-Virella
The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes.
Frontiers in endocrinology 2012;3():76.
2011: Junfei Jin; Yanchun Li; Maria F Lopes-Virella; Zhongyang Lu; Devadoss J Samuvel; Xiaoming Zhang; Yan Huang
Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells.
Molecular immunology 2011;49(3):423-32.
2011: Devadoss J Samuvel; Kamala P Sundararaj; Xiaoming Zhang; Junfei Jin; Yanchun Li; Maria F Lopes-Virella; Yan Huang
TLR4 activation and IL-6-mediated cross talk between adipocytes and mononuclear cells synergistically stimulate MMP-1 expression.
Endocrinology 2011;152(12):4662-71.
2011: Nga N Ta; Yanchun Li; Maria F Lopes-Virella; Corinne A Schuyler; Yan Huang
DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice.
Journal of cardiovascular pharmacology 2011;58(2):157-66.
2011: Corinne A Schuyler; Nga N Ta; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Insulin treatment attenuates diabetes-increased atherosclerotic intimal lesions and matrix metalloproteinase 9 expression in apolipoprotein E-deficient mice.
The Journal of endocrinology 2011;210(1):37-46.
2011: Souzan A Abdelsamie; Yanchun Li; Yan Huang; Mi-Hye Lee; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella
Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III.
Clinical immunology (Orlando, Fla.) 2011;139(3):258-66.
2011: Richard L Klein; Rickey E Carter; Alicia J Jenkins; Timothy J Lyons; Nathaniel L Baker; Gregory Gilbert; Gabriel Virella; Maria F Lopes-Virella
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.
Journal of diabetes and its complications 2011;25(2):73-82.
2011: Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; John Lachin; David Nathan; Gabriel Virella
Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.
Atherosclerosis 2011;214(2):462-7.
2011: Maria F Lopes-Virella; Kelly J Hunt; Nathaniel L Baker; John Lachin; David M Nathan; Gabriel Virella
Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
Diabetes 2011;60(2):582-9.
2010: Nga N Ta; Yanchun Li; Corinne A Schuyler; Maria F Lopes-Virella; Yan Huang
DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes.
Atherosclerosis 2010;213(2):429-35.
2010: Mi-Hye Lee; Samar M Hammad; Andrea J Semler; Louis M Luttrell; Maria F Lopes-Virella; Richard L Klein
HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.
Journal of lipid research 2010;51(9):2619-28.
2010: Kent J Smith; Waleed O Twal; Farzan Soodavar; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad
Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages.
The Journal of biological chemistry 2010;285(21):15985-93.
2010: Devadoss J Samuvel; Kamala Sundararaj; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6-mediated mechanism.
The Journal of biological chemistry 2010;285(6):3916-27.
2010: Mohammed M Al Gadban; Kent J Smith; Farzan Soodavar; Christabelle Piansay; Charlyne Chassereau; Waleed O Twal; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad
Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress.
PloS one 2010;5(9):.
2010: Maria F Lopes-Virella; Gabriel Virella
Clinical significance of the humoral immune response to modified LDL.
Clinical immunology (Orlando, Fla.) 2010;134(1):55-65.
2009: Andrew D Paterson; Maria F Lopes-Virella; Daryl Waggott; Andrew P Boright; S Mohsen Hosseini; Rickey Carter; Enqing Shen; Lucia Mirea; Bhupinder Bharaj; Lei Sun; Shelley B Bull
Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(11):1958-67.
2009: Jyotika K. Fernandes; Ryan E Wiegand; Carlos F Salinas; Sara G Grossi; John J Sanders; Maria F Lopes-Virella; Elizabeth Slate
Periodontal disease status in gullah african americans with type 2 diabetes living in South Carolina.
Journal of periodontology 2009;80(7):1062-8.
2009: Kamala P Sundararaj; Devadoss J Samuvel; Yanchun Li; John J Sanders; Maria F Lopes-Virella; Yan Huang
Interleukin-6 released from fibroblasts is essential for up-regulation of matrix metalloproteinase-1 expression by U937 macrophages in coculture: cross-talking between fibroblasts and U937 macrophages exposed to high glucose.
The Journal of biological chemistry 2009;284(20):13714-24.
2009: Devadoss J Samuvel; Kamala P Sundararaj; Alena Nareika; Maria F Lopes-Virella; Yan Huang
Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(4):2476-84.
2009: Samar M Hammad; Waleed O Twal; Jeremy L Barth; Kent J Smith; Antonio F Saad; Gabriel Virella; Scott Argraves; Maria F Lopes-Virella
Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.
Atherosclerosis 2009;202(2):394-404.
2009: Alena Nareika; Kamala Sundararaj; Yeong-Bin Im; Bryan A Game; Maria F Lopes-Virella; Yan Huang
High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity.
Atherosclerosis 2009;202(2):363-71.
2008: C M Cole; Kamala Sundararaj; Renata S. Leite; Alena Nareika; Elizabeth Slate; John J Sanders; Maria F Lopes-Virella; Yan Huang
A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases.
Journal of periodontal research 2008;43(6):717-22.
2008: W Virgil Brown; Luther Clark; James M Falko; John R Guyton; Tomas J Rees; Gustav Schonfeld; Maria F Lopes-Virella
Optimal management of lipids in diabetes and metabolic syndrome.
Journal of clinical lipidology 2008;2(5):335-42.
2008: Maria F Lopes-Virella; Rickey Carter; Gregory Gilbert; Richard L Klein; Miran Jaffa; Alicia J Jenkins; Timothy J Lyons; W Timothy Garvey; Gabriel Virella
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.
Diabetes care 2008;31(10):2006-12.
2008: Kamala P Sundararaj; Devadoss J Samuvel; Yanchun Li; Alena Nareika; Elizabeth Slate; John J Sanders; Maria F Lopes-Virella; Yan Huang
Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation.
Journal of leukocyte biology 2008;84(4):1120-9.
2008: Gabriel Virella; Maria F Lopes-Virella
Atherogenesis and the humoral immune response to modified lipoproteins.
Atherosclerosis 2008;200(2):239-46.
2008: Gabriel Virella; Rickey Carter; Antonio Saad; Edward G Crosswell; Bryan A Game; Maria F Lopes-Virella
Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.
Clinical immunology (Orlando, Fla.) 2008;127(3):394-400.
2008: Ayad A Jaffa; William R Usinger; M Brent McHenry; Miran A Jaffa; Stuart R Lipstiz; Daniel T Lackland; Maria F Lopes-Virella; Louis M Luttrell; Peter W F Wilson
Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.
The Journal of clinical endocrinology and metabolism 2008;93(5):1893-900.
2008: Jonathan W C Brock; Alicia J Jenkins; Timothy J Lyons; Richard L Klein; Eunsil Yim; Maria F Lopes-Virella; Rickey Carter; Suzanne R Thorpe; John W Baynes
Increased methionine sulfoxide content of apoA-I in type 1 diabetes.
Journal of lipid research 2008;49(4):847-55.
2008: Alena Nareika; Yeong-Bin Im; Bryan A Game; Elizabeth Slate; John J Sanders; Steven D London; Maria F Lopes-Virella; Yan Huang
High glucose enhances lipopolysaccharide-stimulated CD14 expression in U937 mononuclear cells by increasing nuclear factor kappaB and AP-1 activities.
The Journal of endocrinology 2008;196(1):45-55.
2007: Rickey Carter; Daniel T Lackland; Patricia A Cleary; Eunsil Yim; Maria F Lopes-Virella; Gregory Gilbert; Trevor J Orchard
Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial.
Diabetes care 2007;30(10):2646-8.
2007: Bryan A Game; Lin He; Veronica Jarido; Alena Nareika; Ayad A Jaffa; Maria F Lopes-Virella; Yan Huang
Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice.
Atherosclerosis 2007;192(1):85-91.
2007: Alena Nareika; Alejandro Maldonado; Lin He; Bryan A Game; Elizabeth Slate; John J Sanders; Steven D London; Maria F Lopes-Virella; Yan Huang
High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin.
Journal of periodontal research 2007;42(1):31-8.
2007: Maria F Lopes-Virella; M Brent McHenry; Stuart R Lipsitz; Eunsil Yim; Peter F Wilson; Daniel T Lackland; Timothy Lyons; Alicia J Jenkins; Gabriel Virella
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
Atherosclerosis 2007;190(2):359-69.
2006: Timothy J Lyons; Alicia J Jenkins; Deyi Zheng; Richard L Klein; J D Otvos; Y Yu; Daniel T Lackland; Daniel McGee; M Brent McHenry; Maria F Lopes-Virella; W Timothy Garvey
Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(9):955-66.
2006: Antonio F Saad; Gabriel Virella; Charlyne Chassereau; Robert J Boackle; Maria F Lopes-Virella
OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.
Journal of lipid research 2006;47(9):1975-83.
2006: Samar M Hammad; Tarek A Taha; Alena Nareika; Korey R Johnson; Maria F Lopes-Virella; Lina M Obeid
Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells.
Prostaglandins & other lipid mediators 2006;79(1-2):126-40.
2006: Aklilu A Yishak; Tina Costacou; Gabriel Virella; Janice C Zgibor; Linda Fried; Michael Walsh; Rhobert W Evans; Maria F Lopes-Virella; Valerian E Kagan; James D Otvos; Trevor J Orchard
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(1):93-100.
2005: Alena Nareika; Lin He; Bryan A Game; Elizabeth Slate; John J Sanders; Steven D London; Maria F Lopes-Virella; Yan Huang
Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-kappaB transcriptional activities.
American journal of physiology. Endocrinology and metabolism 2005;289(4):E534-42.
2005: Tina Costacou; Maria F Lopes-Virella; Janice C Zgibor; Gabriel Virella; James D Otvos; Michael Walsh; Trevor J Orchard
Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Journal of diabetes and its complications 2005;19(4):183-93.
2005: Maria F Lopes-Virella; Suzanne R Thorpe; M Brooks Derrick; Charlyne Chassereau; Gabriel Virella
The immunogenicity of modified lipoproteins.
Annals of the New York Academy of Sciences 2005;1043():367-78.
2005: Pavel J Kraml; Richard L Klein; Yan Huang; Alena Nareika; Maria F Lopes-Virella
Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes.
Metabolism: clinical and experimental 2005;54(4):453-9.
2005: Gabriel Virella; M Brooks Derrick; Virginia Pate; Charlyne Chassereau; Suzanne R Thorpe; Maria F Lopes-Virella
Development of capture assays for different modifications of human low-density lipoprotein.
Clinical and diagnostic laboratory immunology 2005;12(1):68-75.
2005: Tina Costacou; Janice C Zgibor; Rhobert W Evans; James D Otvos; Maria F Lopes-Virella; R P Tracy; Trevor J Orchard
The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Diabetologia 2005;48(1):41-8.
2004: Alejandro Maldonado; Lin He; Bryan A Game; Alena Nareika; John J Sanders; Steven D London; Maria F Lopes-Virella; Yan Huang
Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histiocytes.
Journal of periodontal research 2004;39(6):415-23.
2004: Gabriel Virella; Suzanne R Thorpe; Nathan L Alderson; M Brooks Derrick; Charlyne Chassereau; J Matthew Rhett; Maria F Lopes-Virella
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.
Journal of lipid research 2004;45(10):1859-67.
2004: Silvana A Vielma; Marina Mironova; Ja-Ran Ku; Maria F Lopes-Virella
Oxidized LDL further enhances expression of adhesion molecules in Chlamydophila pneumoniae-infected endothelial cells.
Journal of lipid research 2004;45(5):873-80.
2004: Maria F Lopes-Virella; Marina Mironova; Elias Stephan; Ramon Durazo-Arvizu; Gabriel Virella
Role of simvastatin as an immunomodulator in type 2 diabetes.
Diabetes care 2004;27(4):908-13.
2003: Maria F Lopes-Virella; Gabriel Virella
The role of immune and inflammatory processes in the development of macrovascular disease in diabetes.
Frontiers in bioscience : a journal and virtual library 2003;8():s750-68.
2003: Bryan A Game; Minfu Xu; Maria F Lopes-Virella; Yan Huang
Regulation of MMP-1 expression in vascular endothelial cells by insulin sensitizing thiazolidinediones.
Atherosclerosis 2003;169(2):235-43.
2003: Gabriel Virella; Maria F Lopes-Virella
Lipoprotein autoantibodies: measurement and significance.
Clinical and diagnostic laboratory immunology 2003;10(4):499-505.
2003: Yuchang Fu; Yan Huang; Sumita Bandyopadhyay; Gabriel Virella; Maria F Lopes-Virella
LDL immune complexes stimulate LDL receptor expression in U937 histiocytes via extracellular signal-regulated kinase and AP-1.
Journal of lipid research 2003;44(7):1315-21.
2003: Silvana A Vielma; Gregor Krings; Maria F Lopes-Virella
Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB.
Circulation research 2003;92(10):1130-7.
2003: Gabriel Virella; Maria F Lopes-Virella
Humoral immunity and atherosclerosis.
Nature medicine 2003;9(3):243-4; author reply 244-5.
2003: Gabriel Virella; Suzanne R Thorpe; Nathan L Alderson; Elias M Stephan; Daniel Atchley; Francesco Wagner; Maria F Lopes-Virella
Autoimmune response to advanced glycosylation end-products of human LDL.
Journal of lipid research 2003;44(3):487-93.
2002: Yuchang Fu; Nanlan Luo; Maria F Lopes-Virella; W Timothy Garvey
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages.
Atherosclerosis 2002;165(2):259-69.
2002: Daniel Atchley; Maria F Lopes-Virella; D Zheng; D Kenny; Gabriel Virella
Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.
Diabetologia 2002;45(11):1562-71.
2002: Gabriel Virella; Daniel Atchley; Sinikka Koskinen; D Zheng; Maria F Lopes-Virella
Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.
Clinical immunology (Orlando, Fla.) 2002;105(1):81-92.
2002: Silvana A Vielma; Gabriel Virella; Adam Gorod; Maria F Lopes-Virella
Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of FC gamma receptor II (FcgammaRII).
Clinical immunology (Orlando, Fla.) 2002;104(3):265-73.
2002: Robert H Eckel; Momtaz Wassef; Alan Chait; Burton Sobel; Eugene Barrett; George King; Maria F Lopes-Virella; Jane E B Reusch; Neil Ruderman; George Steiner; Helen Vlassara
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes.
Circulation 2002;105(18):e138-43.
2002: Fran Anderson; Bryan A Game; Daniel Atchley; Minfu Xu; Maria F Lopes-Virella; Yan Huang
IFN-gamma pretreatment augments immune complex-induced matrix metalloproteinase-1 expression in U937 histiocytes.
Clinical immunology (Orlando, Fla.) 2002;102(2):200-7.
2002: Yuchang Fu; Nanlan Luo; Maria F Lopes-Virella
Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages.
Atherosclerosis 2002;160(1):11-20.
2001: L Song; Minfu Xu; Maria F Lopes-Virella; Yan Huang
Quercetin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase.
Archives of biochemistry and biophysics 2001;391(1):72-8.
2001: Yan Huang; L Song; S Wu; F Fan; Maria F Lopes-Virella
Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells.
Atherosclerosis 2001;156(1):119-25.
2001: Richard L Klein; J L Ascenção; Marina Mironova; Yan Huang; Maria F Lopes-Virella
Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells.
Metabolism: clinical and experimental 2001;50(1):99-106.
2001: A Takei; Yan Huang; Maria F Lopes-Virella
Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL.
Atherosclerosis 2001;154(1):79-86.
2000: Yan Huang; A J Fleming; S Wu; Gabriel Virella; Maria F Lopes-Virella
Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(12):2533-8.
2000: Yuchang Fu; Nanlan Luo; Maria F Lopes-Virella
Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages.
Journal of lipid research 2000;41(12):2017-23.
2000: Maria F Lopes-Virella; Sinikka Koskinen; Marina Mironova; D Horne; Richard L Klein; Charlyne Chassereau; Candace Enockson; Gabriel Virella
The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
Atherosclerosis 2000;152(1):107-15.
2000: Marina Mironova; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella
Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
Diabetes 2000;49(6):1033-41.
2000: James C. Thomas; Maria F Lopes-Virella; V E Del Bene; JD Cerveny; K B Taylor; L S McWhorter; N C Bultemeier
Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities.
Pharmacotherapy 2000;20(6):727-34.
2000: Gabriel Virella; Sinikka Koskinen; Gregor Krings; JM Onorato; Suzanne R Thorpe; Maria F Lopes-Virella
Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.
Clinical immunology (Orlando, Fla.) 2000;95(2):135-44.
1999: Yan Huang; Marina Mironova; Maria F Lopes-Virella
Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(11):2640-7.
1999: Yan Huang; Ayad A Jaffa; Sinikka Koskinen; A Takei; Maria F Lopes-Virella
Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(7):1600-7.
1999: Trevor J Orchard; Gabriel Virella; Kimberly Y Z Forrest; R W Evans; Dorothy J Becker; Maria F Lopes-Virella
Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
Diabetes 1999;48(7):1454-8.
1999: Maria F Lopes-Virella; Gabriel Virella; T J Orchard; Sinikka Koskinen; R W Evans; D J Becker; K Y Forrest
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Clinical immunology (Orlando, Fla.) 1999;90(2):165-72.
1999: S Islam; Bernard Gutin; Frank A Treiber; G Hobbs; I Kamboh; Maria F Lopes-Virella
Association of apolipoprotein A phenotypes and oxidized low-density lipoprotein immune complexes in children.
Archives of pediatrics & adolescent medicine 1999;153(1):57-62.
1998: Steven M Willi; D O'Rear; W Timothy Garvey; John A Colwell; Maria G Buse; Ayad A Jaffa; Maria F Lopes-Virella; D Wood; Ronald Mayfield; Penny Wallace; Kathie L Hermayer; Alicia J Jenkins; Timothy Lyons; Elizabeth J Mayer-Davis
Diabetes research in South Carolina: past, present, and future.
Journal of the South Carolina Medical Association (1975) 1998;94(11):502-8.
1998: Sinikka Koskinen; Candace Enockson; Maria F Lopes-Virella; Gabriel Virella
Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins.
Clinical and diagnostic laboratory immunology 1998;5(6):817-22.
1997: Maria F Lopes-Virella; N Binzafar; S Rackley; A Takei; M La Via; Gabriel Virella
The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor.
Atherosclerosis 1997;135(2):161-70.
1997: Marina Mironova; Gabriel Virella; Isabel Virella-Lowell; Maria F Lopes-Virella
Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.
Clinical immunology and immunopathology 1997;85(1):73-82.
1997: Yan Huang; M J Ghosh; Maria F Lopes-Virella
Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes.
Journal of lipid research 1997;38(1):110-20.
1996: Maria F Lopes-Virella; Gabriel Virella
Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.
Annals of medicine 1996;28(4):347-54.
1996: Maria F Lopes-Virella; Gabriel Virella
Cytokines, modified lipoproteins, and arteriosclerosis in diabetes.
Diabetes 1996;45 Suppl 3():S40-4.
1996: Alicia J Jenkins; Richard L Klein; C N Chassereau; Kathie L Hermayer; Maria F Lopes-Virella
LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
Diabetes 1996;45(6):762-7.
1996: Maria F Lopes-Virella; Richard L Klein; Gabriel Virella
Modification of lipoproteins in diabetes.
Diabetes/metabolism reviews 1996;12(1):69-90.
1996: Marina Mironova; Gabriel Virella; Maria F Lopes-Virella
Isolation and characterization of human antioxidized LDL autoantibodies.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(2):222-9.
1995: Richard L Klein; M Laimins; Maria F Lopes-Virella
Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects.
Diabetes 1995;44(9):1093-8.
1995: R Jokl; Richard L Klein; Maria F Lopes-Virella; John A Colwell
Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.
Diabetes care 1995;18(8):1150-5.
1995: Gabriel Virella; J F Muñoz; G M Galbraith; C Gissinger; C Chassereau; Maria F Lopes-Virella
Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein.
Clinical immunology and immunopathology 1995;75(2):179-89.
1995: Gabriel Virella; Marina Mironova; Maria F Lopes-Virella
Comparing assays of antibodies to modified low-density lipoproteins.
Clinical chemistry 1995;41(2):324-5.
1994: Maria F Lopes-Virella; Gabriel Virella
Atherosclerosis and autoimmunity.
Clinical immunology and immunopathology 1994;73(2):155-67.
1994: R Jokl; M Laimins; Richard L Klein; Timothy J Lyons; Maria F Lopes-Virella; John A Colwell
Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.
Diabetes care 1994;17(8):818-23.
1993: Maria F Lopes-Virella
Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease.
European heart journal 1993;14 Suppl K():118-24.
1993: Richard L Klein; Maria F Lopes-Virella
Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from type 1 (insulin-dependent) diabetic patients.
Diabetologia 1993;36(3):258-64.
1993: Gabriel Virella; Isabel Virella-Lowell; Robert B Leman; M B Pryor; Maria F Lopes-Virella
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.
International journal of clinical & laboratory research 1993;23(2):95-101.
1992: C Gisinger; Maria F Lopes-Virella
Lipoprotein-immune complexes and diabetic vascular complications.
Diabetes 1992;41 Suppl 2():92-6.
1992: Maria F Lopes-Virella; Gabriel Virella
Immune mechanisms of atherosclerosis in diabetes mellitus.
Diabetes 1992;41 Suppl 2():86-91.
1992: Richard L Klein; H J Wohltmann; Maria F Lopes-Virella
Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages.
Diabetes 1992;41(10):1301-7.
1992: Maria F Lopes-Virella; Gabriel Virella
Lipoproteins and immune responses in the vascular wall and their contribution to atherosclerosis in diabetes.
Metabolism: clinical and experimental 1992;41(5 Suppl 1):11-5.
1991: Gabriel Virella; K Fourspring; B Hyman; R Haskill-Stroud; L Long; Isabel Virella-Lowell; M La Via; A J Gross; Maria F Lopes-Virella
Immunosuppressive effects of fish oil in normal human volunteers: correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes.
Clinical immunology and immunopathology 1991;61(2 Pt 1):161-76.
1991: Maria F Lopes-Virella; R L Griffith; K A Shunk; Gabriel Virella
Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(5):1356-67.
1991: C Gisinger; Gabriel Virella; Maria F Lopes-Virella
Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophages.
Clinical immunology and immunopathology 1991;59(1):37-52.
1991: Maria F Lopes-Virella; Gabriel Virella
Immune mechanisms in the pathogenesis of atherosclerosis.
Advances in experimental medicine and biology 1991;285():383-92.
1990: Richard L Klein; T J Lyons; Maria F Lopes-Virella
Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages.
Diabetologia 1990;33(5):299-305.
1989: Richard L Klein; T J Lyons; Maria F Lopes-Virella
Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages.
Metabolism: clinical and experimental 1989;38(11):1108-14.
1989: M Vaughn; Gabriel Virella; Maria F Lopes-Virella
Diabetes, autoimmunity, and arteriosclerosis.
Clinical immunology and immunopathology 1989;52(3):414-20.
1989: P A Marken; C Wayne Weart; Deborah Stier Carson; J G Gums; Maria F Lopes-Virella
Effects of magnesium oxide on the lipid profile of healthy volunteers.
Atherosclerosis 1989;77(1):37-42.
1988: J Watanabe; H J Wohltmann; Richard L Klein; John A Colwell; Maria F Lopes-Virella
Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients.
Diabetes 1988;37(12):1652-7.
1988: John A Colwell; Maria F Lopes-Virella
A review of the development of large-vessel disease in diabetes mellitus.
The American journal of medicine 1988;85(5A):113-8.
1988: R L Griffith; Gabriel Virella; H C Stevenson; Maria F Lopes-Virella
Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.
The Journal of experimental medicine 1988;168(3):1041-59.
1988: Maria F Lopes-Virella; Richard L Klein; Timothy J Lyons; H C Stevenson; J L Witztum
Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages.
Diabetes 1988;37(5):550-7.
1987: T J Lyons; Richard L Klein; John W Baynes; H C Stevenson; Maria F Lopes-Virella
Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins.
Diabetologia 1987;30(12):916-23.
1987: Gabriel Virella; Maria F Lopes-Virella
Infections and atherosclerosis.
Transplantation proceedings 1987;19(4 Suppl 5):26-35.
1987: Maria F Lopes-Virella; John A Colwell
Pharmacological treatment of lipid disorders in diabetes mellitus.
Diabetes/metabolism reviews 1987;3(3):691-722.
1987: Maria F Lopes-Virella; Richard L Klein; H C Stevenson
Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products.
Arteriosclerosis (Dallas, Tex.) 1987;7(2):176-84.
1987: Maria F Lopes-Virella
[Metabolism of lipoproteins in diabetes mellitus].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1987;():55-66.
1986: T J Lyons; John W Baynes; J S Patrick; John A Colwell; Maria F Lopes-Virella
Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control.
Diabetologia 1986;29(10):685-9.
1985: Maria F Lopes-Virella; Gabriel Virella
Immunological and microbiological factors in the pathogenesis of atherosclerosis.
Clinical immunology and immunopathology 1985;37(3):377-86.
1985: Maria F Lopes-Virella; G Sherer; H Wohltmann; D Sens; John A Colwell
Diabetic lipoprotein deficient serum: its effect in low density lipoprotein (LDL) uptake and degradation by fibroblasts.
Metabolism: clinical and experimental 1985;34(12):1079-85.
1985: Ronald Mayfield; Perry V Halushka; H J Wohltmann; Maria F Lopes-Virella; J K Chambers; C B Loadholt; John A Colwell
Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients.
Diabetes 1985;34(11):1127-33.
1985: P D Winocour; Maria F Lopes-Virella; M Laimins; John A Colwell
Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
The Journal of laboratory and clinical medicine 1985;106(3):319-25.
1985: Maria F Lopes-Virella
Abnormal metabolism of low density lipoprotein in diabetes mellitus.
Hormone and metabolic research. Supplement series 1985;15():83-7.
1983: John A Colwell; P D Winocour; Maria F Lopes-Virella; Perry V Halushka
New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.
The American journal of medicine 1983;75(5B):67-80.
1983: P D Winocour; Maria F Lopes-Virella; M Laimins; John A Colwell
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
The Journal of laboratory and clinical medicine 1983;102(5):795-804.
1983: Gabriel Virella; Maria F Lopes-Virella; C Shuler; T Sherwood; G A Espinoza; P Winocour; John A Colwell
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes.
Immunology 1983;50(1):43-51.
1983: Maria F Lopes-Virella; H J Wohltmann; Ronald Mayfield; C B Loadholt; John A Colwell
Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study.
Diabetes 1983;32(1):20-5.
1982: Maria F Lopes-Virella; G K Sherer; A M Lees; H Wohltmann; Ronald Mayfield; Julius Sagel; E C LeRoy; John A Colwell
Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control.
Diabetologia 1982;22(6):430-6.
1981: Maria F Lopes-Virella; H J Wohltmann; C B Loadholt; Maria G Buse
Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control.
Diabetologia 1981;21(3):216-23.
1981: Gabriel Virella; H Wohltmann; Julius Sagel; Maria F Lopes-Virella; M Kilpatrick; C Phillips; John A Colwell
Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance.
Diabetologia 1981;21(3):184-91.
1981: John A Colwell; Maria F Lopes-Virella; Perry V Halushka
Pathogenesis of atherosclerosis in diabetes mellitus.
Diabetes care 1981;4(1):121-33.
1980: Maria F Lopes-Virella; Gabriel Virella; G Evans; S B Malenkos; John A Colwell
Immunonephelometric assay of human apolipoprotein AI.
Clinical chemistry 1980;26(8):1205-8.
1980: Leonie Gordon; Ronald Mayfield; J H Levine; Maria F Lopes-Virella; Julius Sagel; Maria G Buse
Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(1):49-51.
1979: Julius Sagel; Maria F Lopes-Virella; J H Levine; John A Colwell
Decreased high density lipoprotein cholesterol in hypopituitarism.
The Journal of clinical endocrinology and metabolism 1979;49(5):753-6.
1979: Maria F Lopes-Virella; Gabriel Virella; M Debeukelaer; C J Owens; John A Colwell
Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies.
Clinica chimica acta; international journal of clinical chemistry 1979;94(1):73-81.
1979: Maria F Lopes-Virella; Gabriel Virella; G Rosebrock; Julius Sagel; J Gonzalez; J Colwell
Early diagnosis of renal malfunction in diabetics. Abnormal proteinuria revealed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Diabetologia 1979;16(3):165-71.
1979: Gabriel Virella; J Munoz; Maria F Lopes-Virella; B Ward; R Gadsden
Rapid immunochemical determination of free hemoglobin in plasma and urine with a laser nephelometer.
Clinical chemistry 1979;25(3):497-9.
1979: John A Colwell; Perry V Halushka; K E Sarji; Maria F Lopes-Virella; Julius Sagel
Vascular disease in diabetes: pathophysiological mechanisms and therapy.
Archives of internal medicine 1979;139(2):225-30.
1978: Gabriel Virella; Maria F Lopes-Virella; J Levine; M Ogawa; J Gonzalez
"Idiopathic" Bence-Jones proteinuria.
Acta haematologica 1978;60(5):269-79.
1977: Gabriel Virella; Maria F Lopes-Virella
New approaches to the study of proteinuria.
Clinical chemistry 1977;23(9):1793-4.
1977: Maria F Lopes-Virella; P G Stone; John A Colwell
Serum high density lipoprotein in diabetic patients.
Diabetologia 1977;13(4):285-91.
1977: Gabriel Virella; J M Monteiro; Maria F Lopes-Virella; A Ducla Soares; H H Fudenberg
Asynchronous development of two monoclonal proteins (IgM lambda and delta 1 chains) in a patient with abdominal lymphoma.
Cancer 1977;39(5):2247-53.
1977: Maria F Lopes-Virella; P Stone; S Ellis; John A Colwell
Cholesterol determination in high-density lipoproteins separated by three different methods.
Clinical chemistry 1977;23(5):882-4.
1976: Maria F Lopes-Virella; K Sarji; Gabriel Virella; John A Colwell
Platelet lipoproteins. A comparative study with serum lipoproteins.
Biochimica et biophysica acta 1976;439(2):339-48.
1976: Maria F Lopes-Virella; John A Colwell
Serum-high-density-lipoprotein in diabetic patients.
Lancet 1976;1(7972):1291-2.
1970: Gabriel Virella; Maria F Lopes-Virella
Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins.
Clinical and experimental immunology 1970;7(1):85-107.